Dr. Rehile Zengin

P-2333. Evaluation of Clinical Characteristics, Risk Factors and Prognosis of Herpes Zoster (Shingles) Infection in Türkiye: VARICOMP-Adult-2 Study

Open Forum Infectious Diseases, 2025

DOI 10.1093/ofid/ofae631.2485 Open-access full textSource: OpenAlex

Evaluation of clinical characteristics, risk factors and prognosis of herpes zoster (shingles) infection in Türkiye: VARICOMP-adult-2 study

International Journal of Infectious Diseases, 2025

DOI 10.1016/j.ijid.2025.108105 PMID 41067603 Open-access full textSource: OpenAlex

Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions

Scientific Reports, 2024

DOI 10.1038/s41598-024-77259-z PMID 39487308 11 citations (Europe PMC) Open-access full textSource: OpenAlex

The usage of immunosuppressant agents and secondary infections in patients with COVID-19 in the intensive care unit: a retrospective study

Scientific Reports, 2024

DOI 10.1038/s41598-024-71912-3 PMID 39251824 2 citations (Europe PMC) Open-access full textSource: OpenAlex

Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

Antibiotics, 2024

DOI 10.3390/antibiotics13100990 PMID 39452256 7 citations (Europe PMC) Open-access full textSource: OpenAlex

Can CMV reactivation be a biomarker of persistent inflammation, immunosuppression, and catabolism syndrome?

Journal of Critical Care, 2024

DOI 10.1016/j.jcrc.2024.154742 Source: OpenAlex

Ceftazidime-Avibactam versus Polymyxin-Based Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48 Endemic Region

Journal of Global Antimicrobial Resistance, 2024

DOI 10.1016/j.jgar.2024.10.005 Open-access full textSource: OpenAlex

Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection

Research Square, 2023

DOI 10.21203/rs.3.rs-1042702/v2 Source: OpenAlex

Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection

Research Square, 2023

DOI 10.21203/rs.3.rs-1042702/v3 Open-access full textSource: OpenAlex

P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

HemaSphere, 2023

DOI 10.1097/01.hs9.0000972476.61639.77 Source: OpenAlex

Sepsis biomarkers for early diagnosis of bacteremia in emergency department

The Journal of Infection in Developing Countries, 2023

DOI 10.3855/jidc.17221 PMID 37406061 5 citations (Europe PMC) Open-access full textSource: OpenAlex

Is SARS-CoV-2 viral load a predictor of mortality in COVID-19 acute respiratory distress syndrome patients?

Journal of International Medical Research, 2022

DOI 10.1177/03000605221137443 PMID 36448528 5 citations (Europe PMC) Open-access full textSource: OpenAlex

Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection

Research Square, 2021

DOI 10.21203/rs.3.rs-1042702/v1 Source: OpenAlex

THE EFFECTIVENESS OF ACB-IP 1.0 UNIVERSAL PATHOGEN FREE CONCENTRATED COCKTAIL CONVALESCENT PLASMA IN COVID-19 INFECTION

medRxiv, 2021

DOI 10.1101/2021.03.05.21251413 Open-access full textSource: OpenAlex

Human Metapneumovirus Infection in Adults as the Differential Diagnosis of COVID-19

Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi, 2021

DOI 10.4274/tybd.galenos.2020.62207 1 citation (OpenAlex) Open-access full textSource: OpenAlex

Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection

Radiology, 2020

DOI 10.1148/radiol.2020201697 PMID 32384020 219 citations (Europe PMC) Open-access full textSource: OpenAlex

Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series

Brain Behavior and Immunity, 2020

DOI 10.1016/j.bbi.2020.05.022 PMID 32389697 97 citations (Europe PMC) Open-access full textSource: OpenAlex

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection

New Microbes and New Infections, 2020

DOI 10.1016/j.nmni.2020.100756 PMID 32922804 37 citations (Europe PMC) Open-access full textSource: OpenAlex

Preliminary Report of In vitro and In vivo Effectiveness of Dornase Alfa on SARS-CoV-2 Infection (Preprint)

2020

DOI 10.2196/preprints.20121 Source: OpenAlex

Mesenchymal Stromal Cell Therapy For Critically Ill Patients With COVID-19 (Preprint)

2020

DOI 10.2196/preprints.20206 Source: OpenAlex

Preliminary Report of In vitro and In vivo Effectiveness of Dornase Alfa on SARS-CoV-2 Infection (Preprint)

2020

DOI 10.2196/preprints.20200 Source: OpenAlex

Mesenchymal stem cell treatment in a critically ill COVID-19 patient: a case report

Stem Cell Investigation, 2020

DOI 10.21037/sci-2020-024 PMID 33110915 18 citations (Europe PMC) Open-access full textSource: OpenAlex

Adverse Cardiac Events Related to Hydroxychloroquine Prophylaxis and Treatment of COVID-19

Infectious Diseases and Clinical Microbiology, 2020

DOI 10.36519/idcm.2020.0012 9 citations (OpenAlex) Open-access full textSource: OpenAlex

Standart Protokol ile Tedavi Edilen COVID-19 Pnömonisi Hastaları: Beş Yoğun Bakım Ünitesinin Gözlemsel Sonuçları

Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi, 2020

DOI 10.4274/tybd.galenos.2020.57441 3 citations (OpenAlex) Open-access full textSource: OpenAlex

Clinical Outcome and Characteristics of Turkish Breast Cancer Patients who had SARS-Cov-2 Infection

Source: acibadem.com.tr profile page

P-097 The usage of the immunosuppressant agents and secondary şnfections in patients with COVİD-19 in intensive care unit: a retrospective study

Source: acibadem.com.tr profile page

Patients with COVID-19 Pneumonia Treated with the Standart Protocol: Observational Results of Five Intensive Care Units

Source: acibadem.com.tr profile page